The Motley Fool
17 Sept 2026, 08:00 UTC · 2h ago
Verdict
Headline takes no side. We score RVMD +0.90 across three claims — strongly bullish.
+0.90strongly bullish
More positive than 95% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish · 0 new · 3 priced in
Revolution Medicines received approval for RASONQUE, an oral tablet for the treatment of pancreatic adenocarcinoma.
Priced inanalysis of existing product approval
So whatThe drug's phase 3 median overall survival of 13.2 months is nearly double the 6.7 months for chemotherapy, positioning it to replace the current standard of care.
More positive than 98% of claims this week
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
The company set the price of RASONQUE at $39,800 for a 30-day supply.
Priced inanalysis of existing product approval
So whatThe premium pricing relative to Keytruda suggests an aggressive strategy to maximize margins on its first commercial product.
More positive than 85% of claims this week
Revolution Medicines is testing RASONQUE in other indications, including non-small cell lung cancer.
Priced inanalysis of existing product approval
More positive than 77% of claims this week
Which stocks this story touches
More positive than 95% of ticker scores this week
The company received approval for its first product, RASONQUE, which showed significantly better survival rates than chemotherapy in clinical trials.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Seeking Alpha
16h ago
—
RVMD hasn't traded since this ran. Last close $195.92 (Sep 16); the reaction starts at the next open.
RVMD chart →
